<DOC>
	<DOCNO>NCT02245269</DOCNO>
	<brief_summary>Study determine effect combine tipranavir ritonavir treatment ( steady-state ) single-dose pharmacokinetics atorvastatin , effect single-dose atorvastatin steady-state pharmacokinetics tipranavir , effect antacid pharmacokinetics tipranavir</brief_summary>
	<brief_title>Pharmacokinetics Atorvastatin With Tipranavir/Ritonavir Effect Antacid Pharmacokinetics Single-Dose Tipranavir/Ritonavir Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Tipranavir</mesh_term>
	<mesh_term>Aluminum hydroxide , magnesium hydroxide , drug combination</mesh_term>
	<mesh_term>Antacids</mesh_term>
	<mesh_term>Anti-Ulcer Agents</mesh_term>
	<criteria>1 . Male female subject 18 60 year age inclusive 2 . A Body Mass Index ( BMI ) 18 29 kg/m2 3 . Signed informed consent prior trial participation 4 . Ability swallow numerous study medication 5 . Acceptable laboratory value indicate adequate baseline organ function require time screen . Laboratory value consider acceptable severity less equal Grade 1 , base AIDS Clinical Trials Group Grading Scale 6 . Acceptable medical history , physical examination ECG , chest Xray ( conduct within last 12 month ) require prior enter treatment phase study 7 . Willingness abstain alcohol start 2 day prior administration study drug end study . Red wine must ingest within 5 day prior treatment throughout study 8 . Willingness abstain follow start 10 day prior administration study drug end study : • Grapefruit grapefruit juice product contain grapefruit juice 9 . Willingness abstain ingest Seville orange , garlic supplement , St. John 's Wort , Milk Thistle , within 5 day treatment duration study 10 . Willingness abstain methylxanthinecontaining drink food ( coffee , tea , cola , energy drink , chocolate , etc . ) within 72 hour pharmacokinetic ( PK ) sample day last sample intensive sampling day collect 11 . Willingness abstain counter herbal medication duration study 12 . Willingness abstain vigorous physical exercise PK Days 13 . Reasonable probability completion study 1 . Female subject reproductive potential : Have positive serum βhuman chorionic gonadotropin Visit 1 , Day 0 Have use barrier contraceptive method least 3 month prior Day 0 ( Visit 2 ) Are willing use reliable method barrier contraception ( diaphragm condom ) , trial 30 day completion/termination Are breastfeed 2 . Use pharmacological contraceptive ( include oral , patch injectable contraceptive ) 1 month prior study initiation duration study 3 . Use hormone replacement therapy 1 month prior study initiation duration study 4 . Participation another trial investigational medicine within 60 day prior Day 0 ( Visit 2 ) 5 . Use medication list protocol within 30 day prior Day 0 ( Visit 2 ) 6 . Administration antibiotic within 10 day prior Day 0 ( Visit 2 ) trial 7 . History acute illness within past sixty ( 60 ) day . Subjects exclude disorder great sixty day , opinion investigator , subject qualify healthy volunteer 8 . Have serological evidence Hepatitis B C Virus 9 . Have serological evidence exposure HIV 10 . Recent history alcohol substance abuse ( within 6 month study period ) 11 . Smokers smoke great 10 cigarette 3 cigar 3 pipe per day ; inability refrain smoke trial 12 . Blood plasma donation within 30 day prior Day 0 ( Visit 2 ) trial 13 . Subjects seat systolic blood pressure either &lt; 100 mm Hg &gt; 150 mm Hg ; rest heart rate either &lt; 50 beats/min &gt; 90 beats/min 14 . Subjects history illness allergy , opinion investigator , might confound result study pose additional risk administer Tipranavir , Ritonavir , atorvastatin erythromycin subject 15 . Subjects currently take overthecounter drug within 7 day prior Day 0 , ( Visit 2 ) currently take prescription drug , opinion investigator consultation clinical monitor , might interfere either absorption , distribution metabolism test substances 16 . Known hypersensitivity Tipranavir , Ritonavir , sulfonamide , atorvastatin , erythromycin saccharin 17 . Inability comply protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>22 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>